Aptinyx (APTX:NAS) and ASLAN Pharmaceuticals (ASLN:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
SOHU Sohu.com Ltd 20.000000 39228538 None 1.4657 21.38 12.30
PRTA Prothena Corp PLC 10.560000 39863711 None 1.3033 10.73 9.43
FTR Frontier Communications Corp 2.060000 105318646 None 0.1455 3.36 -159.69
TA TravelCenters of America LLC 4.020000 40397551 None 0.3618 7.78 -9.95
NHTC Natural Health Trends Corp 11.510000 11398695 4.2007 1.4600 11.64 0.13
APTX Aptinyx Inc 3.780000 33562211 None 0.8497 4.49 None
ASLN ASLAN Pharmaceuticals Ltd 3.650000 32049788 None 3.8207 27.57 14.24
SORL SORL Auto Parts Inc 3.710000 19304921 5.6212 0.4054 3.81 -9.32
SCPH scPharmaceuticals Inc 3.600000 18580430 None 0.8495 4.82 4.30
NLNK NewLink Genetics Corp 1.790000 37276102 None 0.5795 3.24 3.24
CDTX Cidara Therapeutics Inc 2.440000 26641851 None 1.0992 2.80 2.43
AQXP Aquinox Pharmaceuticals Inc 2.690000 23537368 None 0.8713 3.27 3.27
MLNT Melinta Therapeutics Inc 4.620000 11779897 None 0.2863 6.94 -2.43
TST TheStreet Inc 6.890000 5336639 3.2090 0.6617 6.94 8.63
PDSB PDS Biotechnology Corp 5.870000 5348174 None 1.0521 6.48 10.11
APWC Asia Pacific Wire & Cable Corp Ltd 2.240000 13819669 10.6667 0.2063 4.40 2.60
ADXS Advaxis Inc 3.570000 8006984 None 0.7623 4.09 14.08
GIGM GigaMedia Ltd 2.480000 11052235 28.0000 0.4756 5.25 5.77
GEVO Gevo Inc 2.122500 11885678 None 0.2841 2.84 1.78
TNXP Tonix Pharmaceuticals Holding Corp 2.100000 6089728 None 0.5404 4.11 7.16
CLRB Cellectar Biosciences Inc 2.420000 5102709 None 1.1503 2.60 2.60
MDGS Medigus Ltd 2.789200 3796602 None 1.3107 2.80 None
KBSF KBS Fashion Group Ltd 3.847500 2228497 None 0.1579 9.07 8.58
BLIN Bridgeline Digital Inc 5.310000 324825 None 0.4403 6.47 -1.29
JMU JMU Ltd 1.640000 819615 None 0.0661 12.09 3.21

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

APTX:NAS Aptinyx

https://www.aptinyx.com
Aptinyx has 63 employees and is headquartered in United States.
Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.

ASLN:NAS ASLAN Pharmaceuticals

http://www.aslanpharma.com
ASLAN Pharmaceuticals has 56 employees and is headquartered in Singapore.
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.